Nils Billestrup

Nils Billestrup

Professor

Member of:

    ORCID: 0000-0002-4968-8067

    Publication year:
    All
    1 - 2 out of 2Page size: 10
    1. 2017
    2. Published

      In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

      Skarbaliene, J., Rigbolt, K. T., Fosgerau, K. & Billestrup, Nils, 15 Nov 2017, In: European Journal of Pharmacology. 815, p. 181-189 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Pannexin-2-deficiency sensitizes pancreatic beta-cells to cytokine-induced apoptosis in vitro and impairs glucose tolerance in vivo

      Berchtold, L. A., Miani, M., Diep, T. A., Madsen, A. N., Cigliola, V., Colli, M., Miskovic Krivokapic, Jelena, Pociot, Flemming, Eizirik, D. L., Meda, P., Holst, Birgitte, Billestrup, Nils & Storling, J., 2017, In: Molecular and Cellular Endocrinology. 448, p. 108-121 4 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 15311848